免疫
生物
细胞毒性T细胞
免疫系统
CD8型
免疫学
过继性细胞移植
结直肠癌
癌症研究
先天性淋巴细胞
获得性免疫系统
T细胞
癌症
体外
生物化学
遗传学
作者
Abigail E Overacre-Delgoffe,Hannah Bumgarner,Anthony R. Cillo,Ansen H.P. Burr,Justin T. Tometich,Amrita Bhattacharjee,Tullia C. Bruno,Dario A.A. Vignali,Timothy W. Hand
出处
期刊:Immunity
[Elsevier]
日期:2021-12-01
卷期号:54 (12): 2812-2824.e4
被引量:163
标识
DOI:10.1016/j.immuni.2021.11.003
摘要
The composition of the intestinal microbiota is associated with both the development of tumors and the efficacy of anti-tumor immunity. Here, we examined the impact of microbiota-specific T cells in anti-colorectal cancer (CRC) immunity. Introduction of Helicobacter hepaticus (Hhep) in a mouse model of CRC did not alter the microbial landscape but increased tumor infiltration by cytotoxic lymphocytes and inhibited tumor growth. Anti-tumor immunity was independent of CD8+ T cells but dependent upon CD4+ T cells, B cells, and natural killer (NK) cells. Hhep colonization induced Hhep-specific T follicular helper (Tfh) cells, increased the number of colon Tfh cells, and supported the maturation of Hhep+ tumor-adjacent tertiary lymphoid structures. Tfh cells were necessary for Hhep-mediated tumor control and immune infiltration, and adoptive transfer of Hhep-specific CD4+ T cells to Tfh cell-deficient Bcl6fl/flCd4Cre mice restored anti-tumor immunity. Thus, introduction of immunogenic intestinal bacteria can promote Tfh-associated anti-tumor immunity in the colon, suggesting therapeutic approaches for the treatment of CRC.
科研通智能强力驱动
Strongly Powered by AbleSci AI